New prediction model study for liver cirrhosis
Part of Digestive system clinical trials.
This study is exploring a new way to predict how liver cirrhosis will progress. It may help doctors better understand and manage the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing and able to sign a consent form.
- You must be between 18 and 75 years old.
- You must have a confirmed diagnosis of liver cirrhosis.
- Your expected survival must be more than 3 months.
- You must be able to make your own medical decisions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how nutrition affects the health of people with liver cirrhosis (scarred liver) and aims to build a tool to predict their outcomes. If you have cirrhosis, joining may help researchers find better ways to support your health.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study looks at how gut bacteria change in people with liver cirrhosis and whether these changes relate to how the disease progresses. It may help find new ways to monitor or treat cirrhosis.
This study looks at new, non-invasive methods to predict when chronic liver disease might get worse. It could help you and your doctor catch problems early without needing a biopsy or other invasive procedures.
This study aims to predict the risk of developing liver cancer in people with chronic liver conditions such as hepatitis B or C, cirrhosis, or fatty liver disease. By participating, you may help researchers improve early detection and prevention strategies for liver cancer.
This study looks at how to predict future outcomes in adults who have fatty-liver disease (NAFLD) that has progressed to cirrhosis. It may help doctors better estimate risk and plan care, using information from liver tests and scans.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.